http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5665731-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4926
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
filingDate 1995-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1997-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da4a6d741c79b2a6a08d712e1229e15c
publicationDate 1997-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5665731-A
titleOfInvention Method and composition for treating with a vasodilator inflammation, bone loss and detachment of teeth as associated with periodontal
abstract A process is provided which is useful in alleviating inflammation of gums, bone loss and detachment of teeth in a patient in need of such treatment. The process comprises administering a vasodilator to the inflamed gum tissue and other affected tissue, either topically or by injection. Advantageously, the vasodilator is papaverine or a pharmaceutically acceptable salt thereof such as papaverine hydrochloride. Advantageously, the papaverine hydrochloride may be administered topically in a composition comprising a carrier such as an aqua based transparent gel dental vehicle. The carrier dissolves the papaverine hydrochloride and enables it to penetrate the soft tissue of the gums and be absorbed into the inflamed tissue.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005226821-A1
priorityDate 1995-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4136173-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4440777-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3823234-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5278172-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2507086-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4529584-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4055648-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5059603-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4529585-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4018927-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4758433-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3910921-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5487897-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4089943-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4801587-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129933766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226492747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4680

Total number of triples: 50.